U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6198161981SILVER-AMI: Outcomes in Older Persons With Heart AttacksEnrolling by invitationNo Results AvailableAcute Myocardial Infarctionhttps://ClinicalTrials.gov/show/NCT01755052
6198261982Course and Complications of Invasive Out-of-hospital VentilationCompletedNo Results AvailableIndication for Invasive Out-of-hospital Ventilationhttps://ClinicalTrials.gov/show/NCT01755039
6198361983Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean DeliveryCompletedHas ResultsCesarean Delivery|Wound Infection|ObesityDrug: cefazolin|Drug: cefazolinhttps://ClinicalTrials.gov/show/NCT01755026
6198461984Photodynamic Therapy (PDT) for Palliation of CholangiocarcinomaRecruitingNo Results AvailableCholangiocarcinoma|Biliary Stricture|Biliary Obstruction|Bile Duct CancerProcedure: Photodynamic Therapyhttps://ClinicalTrials.gov/show/NCT01755013
6198561985Study of Hypotensive Hematopoietic Malignancy Patients' USCOM ReadingsCompletedNo Results AvailableLeukemia|Lymphoma|Paraproteinemias|Multiple Myeloma|Myelodysplastic SyndromesProcedure: USCOM scan|Procedure: Fluid Bolushttps://ClinicalTrials.gov/show/NCT01755000
6198661986A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and EffectiveActive, not recruitingNo Results AvailableMetastatic Hepatocellular Carcinoma|Advanced Liver CancerDrug: Ascorbic Acid + Sorafenib|Drug: Sorafenib alonehttps://ClinicalTrials.gov/show/NCT01754987
6198761987Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis CCompletedNo Results AvailableHepatitis C Virus (HCV)Biological: Peginterferon Lambda-1a|Drug: Ribavirin|Biological: Peginterferon alfa-2ahttps://ClinicalTrials.gov/show/NCT01754974
6198861988Effects of Vitamin D on Inflammation in Liver DiseaseRecruitingNo Results AvailableHepatitis C Infection|Vitamin D DeficiencyDrug: Vitamin D|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01754961
6198961989Biological Monitoring of Nano Sized Particles in the Airways of Asthmatic ChildrenRecruitingNo Results AvailableAsthmahttps://ClinicalTrials.gov/show/NCT01754948
6199061990A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 InhibitorCompletedNo Results AvailableRheumatoid ArthritisDrug: VX-509|Drug: VX-509 matching placebohttps://ClinicalTrials.gov/show/NCT01754935
6199161991Effects of Deployment Exposures on Cardiopulmonary and Autonomic FunctionActive, not recruitingNo Results AvailableAbnormality, Respiratory System|Autonomic Nervous Systemhttps://ClinicalTrials.gov/show/NCT01754922
6199261992Mitigation of Radiation Pneumonitis and FibrosisRecruitingNo Results AvailableLung Cancer|Radiation PneumonitisDrug: Enalapril|Drug: placebohttps://ClinicalTrials.gov/show/NCT01754909
6199361993Pilot Evaluation of Fecal Immunologic Test (FIT) in OntarioCompletedNo Results AvailableColorectal CancerOther: mailing of FIT kit directly to patient|Other: mailed invitation to pick up lab requisition and then kit|Other: mailing completed kits in for processing|Other: dropping completed kits at lab for processinghttps://ClinicalTrials.gov/show/NCT01754896
6199461994Lithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot StudyRecruitingNo Results AvailableCombat Posttraumatic Stess Disorder|Mild Traumatic Brain InjuryDrug: Lithium Carbonatehttps://ClinicalTrials.gov/show/NCT01754883
6199561995Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)WithdrawnNo Results AvailableChronic Lymphocytic Leukemia (CLL)|Small Lymphocytic Lymphoma (SLL)Drug: Bendamustine and Rituximab Induction followed by Rituximab and Lenalidomide Maintenancehttps://ClinicalTrials.gov/show/NCT01754870
6199661996Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)RecruitingNo Results AvailableLymphoid Leukemia|Small Lymphocytic Lymphoma|Lymphoma, Non-HodgkinDrug: Bendamustine Hydrochloride|Drug: Rituximab|Drug: Lenalidomidhttps://ClinicalTrials.gov/show/NCT01754857
6199761997A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy SubjectsCompletedNo Results AvailableChronic Obstructive Pulmonary Disease (COPD)Drug: AZD7624|Drug: Placebo to matchhttps://ClinicalTrials.gov/show/NCT01754844
6199861998Fluoride Administered and Retained After Topical Fluoride VarnishActive, not recruitingNo Results AvailableHealthyDevice: Fluoride varnishhttps://ClinicalTrials.gov/show/NCT01754831
6199961999A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)CompletedNo Results AvailableHealthyDrug: Bendavia 10mg|Drug: Bendavia 50mg|Drug: Bendavia 100mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01754818
6200062000A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Methotrexate in Patients With Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: ASP015K|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT01754805
6200162001Effects of Pinitol on Hidrocarbonated Metabolism Parameters in Diabetic, Impaired and Normal Fasting Glucose SubjectsCompletedNo Results AvailableType 2 Diabetes|Impaired Glucose Tolerance|HealthyDietary Supplement: Pinitolhttps://ClinicalTrials.gov/show/NCT01754792
6200262002Treatment for Calcium Phosphate Kidney Stone DiseaseRecruitingNo Results AvailableCalcium Phosphate Kidney StonesDrug: Placebo|Dietary Supplement: Citric Acid|Dietary Supplement: Potassium Citrate|Drug: Indapamidehttps://ClinicalTrials.gov/show/NCT01754779
6200362003AGN-229666 for the Treatment of Allergic ConjunctivitisCompletedHas ResultsAllergic ConjunctivitisDrug: AGN-229666|Other: vehicle of AGN-229666https://ClinicalTrials.gov/show/NCT01754766
6200462004Putting Life in Years (PLINY): Telephone Friendship Groups Research StudyTerminatedNo Results AvailableSelf Efficacy|LonelinessOther: Telephone Friendship groupshttps://ClinicalTrials.gov/show/NCT01754753
6200562005The Role of Xerostomia in Burning Mouth Syndrome: Case - Control StudyCompletedNo Results AvailableBurning Mouth SyndromeDrug: Uréia|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01754740
6200662006Impact of Adalimumab (Humira) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical PracticeActive, not recruitingNo Results AvailableAnkylosing Spondylitishttps://ClinicalTrials.gov/show/NCT01754727
6200762007Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control GroupCompletedNo Results AvailableNon Alcoholic Fatty Liver DiseaseDrug: SAMe 1000 mg|Drug: SAMe 1500 mg|Drug: SAMe 2000 mghttps://ClinicalTrials.gov/show/NCT01754714
6200862008Acute vs. Delayed Iron: Effect on Red Cell Iron Incorporation in Severe MalariaActive, not recruitingNo Results AvailableIron Deficiency|Malaria|Nutrition|Global HealthDietary Supplement: Ferrous sulfate syrup; iron stable isotope 57Fe; iron stable isotope 58Fehttps://ClinicalTrials.gov/show/NCT01754701
6200962009Determining Prevalence of Acute Bilirubin Encephalopathy in Developing CountriesRecruitingNo Results AvailableDemonstrate BIND II Score of >=5, is Valid for Detecting Moderate to Severe ABE in Neonates - Other: Bilirubin Induced Neurologic Dysfunction II scorehttps://ClinicalTrials.gov/show/NCT01754688
6201062010Cardiovascular Effects of a Soccer Match in Viewers With With Coronary Artery DiseaseCompletedNo Results AvailableCoronary Artery DiseaseBehavioral: Soccer|Behavioral: Moviehttps://ClinicalTrials.gov/show/NCT01754675

* Görseller ve İçerik tekif hakkına sahip olabilir